"Preemptive" live donor liver transplantation for fibrolamellar hepatocellular carcinoma: a case report
- PMID: 19100497
- DOI: 10.1016/j.transproceed.2008.09.050
"Preemptive" live donor liver transplantation for fibrolamellar hepatocellular carcinoma: a case report
Abstract
Fibrolamellar (FL) hepatocellular carcinoma (HCC) is a distinctive form of primary HCC that occurs principally in children and young adults. Although liver transplantation is not contraindicated for FL-HCC, noncirrhotic patients with large HCC tumors (including FL-HCCs) are not prioritized. Although hepatic resection is considered to be the primary treatment for FL-HCC, living donor liver transplantation is evolving into a potentially better alternative. Herein we have reported successful "preemptive" living donor liver transplantation for presumed recurrence of FL-HCC after an extended right hepatectomy with resection and synthetic graft replacement of the inferior vena cava.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
